C81.0
Nodular lymphocyte predominant Hodgkin lymphoma
Clinical Classification Guidelines
Medical Intelligence & Overview
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare type of lymphoma, a cancer that begins in the lymphatic system. The lymphatic system is part of the body's immune defenses, consisting of lymph nodes, spleen, thymus, and bone marrow. NLPHL is distinguished by the presence of specific abnormal cells called lymphocyte predominant cells and generally has a slower progression compared to other types of Hodgkin lymphoma. It most often affects young to middle-aged adults and tends to grow gradually over time. Understanding NLPHL can help patients and caregivers better comprehend diagnosis, treatment options, and prognosis.
Causes & Symptoms
Clinical Causes: The exact cause of NLPHL is unknown. Genetic mutations may play a role in the development of abnormal lymphocytes. Environmental factors have not been clearly linked to the disease. Immune system anomalies may contribute to the risk, although specific triggers are not well established.
Key Symptoms: Painless swelling in the lymph nodes, commonly in the neck, armpits, or groin. Persistent fatigue or weakness. Unexplained weight loss. Fever that is not caused by an infection. Night sweats. Itching over the affected areas. Some patients may experience discomfort or pain in lymph node regions after consuming alcohol, although this is less common.
Diagnostic & Treatment
Diagnosis Path: Diagnosing NLPHL often involves several steps:
Treatment Protocols: Treatment options for NLPHL depend on the disease stage, overall health, and specific features of the lymphoma:
Clinical Advice & FAQs
Billing Guidance
Is C81.0 a billable ICD-10 code?
Yes, C81.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.0?
Clinical documentation must specify the nature of Nodular lymphocyte predominant Hodgkin lymphoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference